Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coffen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|August 4, 1999
Convergent automated parallel synthesisPowers, Coffen
Postgraduate Medicine|October 13, 2009
The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management taskRonald D Coffen
The Diabetes Educator|February 17, 2009
Magnitude of type 1 diabetes self-management in youth: health care needs diabetes educatorsRonald D Coffen, Lynnda M Dahlquist
American Heart Journal|October 29, 2010
Acute pericarditis simulating coronary artery occlusionC W COFFEN, M SCARF
Journal of Biomolecular Screening|November 2, 2001
The integration of high throughput technologies for drug discoveryG P Sabbatini, W A Shirley, D L Coffen
Bioorganic & Medicinal Chemistry|April 1, 1995
An alternate synthesis of the Tat-antagonist 7-chloro-N-methyl-5-(1H-pyrrol-2-yl)-3H-1,4-benzodiazepin-2-amineH Maehr, G Zenchoff, D L Coffen
Journal of the American Chemical Society|June 12, 1974
Rearrangement of benzylidenequinuclidinones to tetrahydropyridoindoles. A novel synthesis of indole alkaloids of the eburnamine typeD L Coffen, D A Katonak, F Wong
The Journal of Experimental Medicine|October 30, 2009
A COMPARISON OF SIMULTANEOUS POLYGRAPH AND MICROGRAPH TRACINGSF S Meara, T H Coffen, A C Crehore
The Journal of Organic Chemistry|March 18, 1977
A short synthesis of aromatic analogues of the aranotinsD L Coffen, D A Katonak, N R Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffoldManish Tandon, David L Coffen, Paul Gallant, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|August 4, 1999
Convergent automated parallel synthesisPowers, Coffen
Postgraduate Medicine|October 13, 2009
The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management taskRonald D Coffen
The Diabetes Educator|February 17, 2009
Magnitude of type 1 diabetes self-management in youth: health care needs diabetes educatorsRonald D Coffen, Lynnda M Dahlquist
American Heart Journal|October 29, 2010
Acute pericarditis simulating coronary artery occlusionC W COFFEN, M SCARF
Journal of Biomolecular Screening|November 2, 2001
The integration of high throughput technologies for drug discoveryG P Sabbatini, W A Shirley, D L Coffen
Bioorganic & Medicinal Chemistry|April 1, 1995
An alternate synthesis of the Tat-antagonist 7-chloro-N-methyl-5-(1H-pyrrol-2-yl)-3H-1,4-benzodiazepin-2-amineH Maehr, G Zenchoff, D L Coffen
Journal of the American Chemical Society|June 12, 1974
Rearrangement of benzylidenequinuclidinones to tetrahydropyridoindoles. A novel synthesis of indole alkaloids of the eburnamine typeD L Coffen, D A Katonak, F Wong
The Journal of Experimental Medicine|October 30, 2009
A COMPARISON OF SIMULTANEOUS POLYGRAPH AND MICROGRAPH TRACINGSF S Meara, T H Coffen, A C Crehore
The Journal of Organic Chemistry|March 18, 1977
A short synthesis of aromatic analogues of the aranotinsD L Coffen, D A Katonak, N R Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffoldManish Tandon, David L Coffen, Paul Gallant, et al.
Pageof 2